/TLX
TLX
Updated 24 Aug 08:16 am
$16.16
TELIX PHARMACEUTICALS LIMITED
1D-3.96%
1M+21.29%
1Y-32.94%
Track your position in TLX
Sign in to TradeLedgr to record trades in TLX (TELIX PHARMACEUTICALS LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
19 Aug 2026 10:42 PM
Telix HY26 Results Presentation2210KB
Company Presentation
19 Aug 2026 10:41 PM
Telix HY26 Results Announcement148KB
Web Cast
19 Aug 2026 10:40 PM
Telix HY26 Appendix 4D and Interim Report7116KB
Half Yearly Report
30 Jul 2026 10:30 PM
Telix H1 2026 Results - Investor Webcast Notification174KB
Notification of Results/Reporting Date
23 Jul 2026 10:21 PM
Change in substantial holding1814KB
Change in substantial holding
Fundamentals
P/E Ratio
112.53x
Div Yield
0.00%
EPS
$0.1388
Avg Vol
1.9M
52W High
$19.070
52W Low
$8.260
Company Profile
Development and commercialising molecularly targeted radiation products for the treatment of cancer.
Financial History
2025A
$-7.1M profit
$803.8M rev
2024A
$33.7M profit
$516.6M rev
2023A
$4.2M profit
$333.0M rev